We use our own cookies and others by third parties to “store and access information regarding language, browser type, and other basic features defined by the user, as well as to trace and analyze the activity carried out, aiming at improving and providing our services in a more efficient and customized fashion”. If you keep navigating, we will consider you accept their use. You may change the configuration or obtain more information here

Skip Ribbon Commands Skip to main content

The pharmaceutical company BIAL and Logista Pharma join forces to guarantee the delivery of medicines from the Hospital to the patients' home

27/04/2020

  • The pharmaceutical company BIAL joins the solidarity action with the initial contribution of several vans
  • With this action, hospitals will have a service to deliver drugs to patients at home

Due to the current health crisis caused by Covid-19, there are many patients at risk, who must stay home and avoid going to hospitals, in order to avoid the exposure to possible sources of contagion of the coronavirus. This confinement makes drugs procurement difficult, especially in the areas most affected by the virus.

Logista Pharma has launched an initiative to provide hospitals with a collection service from hospital pharmacies and the delivery of dispensing medication to patients' homes during the health crisis. In this way, it has permitted a continuous response to patients’ needs, so that their treatments are not interrupted, and also without making them go to the hospital, thus avoiding the risk of infection. This solidarity action has involved the collaboration of BIAL with several vans that will be transferred to different cities in Spain.

In order to face this challenge of home care for patients, the collaboration of the two companies becomes into a contribution of full-time vehicles available for Hospital Pharmaceutical Service for the delivery of medicines to patients without making them going to hospitals, providing also a monitoring of the vehicles’ temperature, call center to health centers, traceability of the route, GPS tracking, packaging for the transport of medicines and guarantee of quality compliance.

Ana Álvarez, General Director of BIAL in Spain, said that “we want to contribute to improve this situation by joining forces and guaranteeing home care for people at risk. From BIAL, we want to collaborate in this initiative due to its relevance in the fight against coronavirus as well as for the health care of patients".

Founded in 1924, BIAL aims to research, develop and provide therapeutic solutions in the area of Health. In the last decades, BIAL has strategically been focused on quality, innovation and internationalization.

BIAL is firmly committed to therapeutic innovation, investing more than 20 percent of its annual turnover in Research and Development (R&D) in the areas of the neurosciences and the cardiovascular system. 

The company hopes to strengthen its international presence by making innovative medicines available to healthcare professionals, patients and their families worldwide, always inspired by its strong motivation: "Keeping life in mind".

Logista Pharma, that belongs to Logista, is the only independent Pharmaceutical Distributor in pharmaceutical distribution to Hospitals in Spain and Portugal, and with a strong presence in distribution to pharmacies. Logista Pharma has the widest range of services for the Pharmaceutical and Healthcare sector, validated by its more than 200 client laboratories.

Logista Pharma relies on the transport companies of Logista, Nacex, Integra2 and Logesta, for the distribution of pharmaceutical products in Spain and Portugal, ensuring full operational integration, physical and thermal traceability in real time, with the highest levels of quality and the use of avant-garde information systems.

Logista is the leading distributor of products and services to local businesses (service stations, pharmacies, hospitals, etc.) in southern Europe, reaching distribution to around 300,000 points of sale in Spain, France, Italy and Portugal, thus facilitating the best and fastest market access for all kinds of products.


Back